ASTELLAS PHARMA financial statements, including revenue, expenses, profit, and loss

The total revenue of 4503 for the last quarter is 462.50 B JPY, and it's 2.25% lower compared to the previous quarter. The net income of Q2 24 is 35.91 B JPY.